Barbara Gayle Duncan, Chief Accounting Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 146 shares at $145.11 ($21K) on 2016-07-05, disclosed to the SEC on 2016-07-07.
Seasonal sale ($21k) by Chief Accounting Officer — this insider has traded ICPT in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| JNCE | SELL | 2018-01-29 | $100K | — | Filing → |
| GNMX | BUY | 2017-10-18 | $150K | — | Filing → |
| ICPT | SELL | 2016-10-05 | $24K | — | Filing → |